1-7 of 7
Tatyana I Ionova
Close
Sort by
Journal Articles

Long-Term Outcomes of Dasatinib Therapy in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia from Physician’s and Patient’s Perspective

Tatyana I Ionova, PhD, Tatyana P Nikitina, PhD, Denis A Fedorenko, MD PhD, Taras A Gritsenko, MD PhD, Valentina L Ivanova, MD PhD, Galina B Kuchma, MD PhD, Tatyana V Shnaider, MD PhD, Inga V Sannikova, MD PhD, Elena I Usacheva, MD PhD, Kira A Kurbatova
Journal: Blood
Blood (2014) 124 (21): 2644.
https://doi.org/10.1182/blood.V124.21.2644.2644
Published: 2014
Journal Articles

Efficacy Of Dasatinib Therapy In Patients With Imatinib-Resistant Or -Intolerant Chronic Myeloid Leukemia From Physician’s and Patient’s Perspective: “Real World” Data

Tatyana I Ionova, PhD, Tatyana P Nikitina, MD, Taras A Gritsenko, MD, PhD, Valentina L Ivanova, MD, PhD, Galina B Kuchma, MD, PhD, Tatyana V Shnaider, MD, PhD, Inga V Sannikova, MD, Denis A Fedorenko, MD, PhD, Kira A Kurbatova
Journal: Blood
Blood (2013) 122 (21): 5185.
https://doi.org/10.1182/blood.V122.21.5185.5185
Published: 2013
Journal Articles

Clinical and Patient-Reported Outcomes of Dasatinib Therapy in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Tatyana I Ionova, PhD, Tatiana P Nikitina, PhD, Taras A Gritsenko, MD, PhD, Valentina L Ivanova, MD, PhD, Galina B Kuchma, MD, PhD, Tatyana V Shnaider, MD, PhD, Denis A Fedorenko, MD, PhD, Kira A Kurbatova, Andrei A Novik, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4445.
https://doi.org/10.1182/blood.V120.21.4445.4445
Published: 2012
Journal Articles

New Instrument for Comprehensive Symptom Profile Assessment In Patients with Malignant Lymphomas

Andrei A Novik, Tatyana I Ionova, Svetlana A Kalyadina, Denis A Fedorenko, Nikita E Mochkin, Kira A Kurbatova, Tatyana P Nikitina, Gary I Gorodokin
Journal: Blood
Blood (2010) 116 (21): 2561.
https://doi.org/10.1182/blood.V116.21.2561.2561
Published: 2010
Journal Articles

Reduced Intensity Conditioning Regimen of Autologous Hematopoietic Stem Cell Transplantation±Mitoxantrone Consolidation In Multiple Sclerosis

Andrei A Novik, Aleksey N Kuznetsov, Vladimir Y Melnichenko, Denis A Fedorenko, Andrei V Kartashov, Tatyana I Ionova, Kira A Kurbatova, Gary I Gorodokin
Journal: Blood
Blood (2010) 116 (21): 372.
https://doi.org/10.1182/blood.V116.21.372.372
Published: 2010
Journal Articles

The Utility of the New Instrument for Comprehensive Symptom Profile Assessment In Patients with Multiple Myeloma

Andrei A Novik, Tatyana I Ionova, Svetlana A Kalyadina, Denis A Fedorenko, Nikita E Mochkin, Kira A Kurbatova, Tatyana P Nikitina, Gary I Gorodokin
Journal: Blood
Blood (2010) 116 (21): 4757.
https://doi.org/10.1182/blood.V116.21.4757.4757
Published: 2010
Journal Articles

Which Strategy of Immunoablative Therapy with Autologous Stem Cell Transplantation (ASCT) Is Preferable in Multiple Sclerosis (MS) Patients?.

Yury L. Shevchenko, Andrei A. Novik, Alexey N. Kuznetcov, Boris A. Afanasiev, Igor A. Lisukov, Oleg A. Rykavicin, Alexandr A. Myasnikov, Tatyana I. Ionova, PhD, Vladimir J. Melnichenko, MD, PhD, Denis A. Fedorenko, MD, PhD, Anton V. Kishtovich, PhD, Roman A. Ivanov, PhD, Gary J. Gorodokin, MD
Journal: Blood
Blood (2007) 110 (11): 5093.
https://doi.org/10.1182/blood.V110.11.5093.5093
Published: 2007